36 / 70
CARDIOVASCULAR JOURNAL OF AFRICA • Volume 27, No 5, September/October 2016
306
AFRICA
cardium, epicardium, and myocardium to large molecules: stretch-
dependent effects.
Circ Res
1992;
71
: 159–173.
16. Tambara K, Fujita M, Nagaya N,
et al.
Increased pericardial fluid
concentrations of the mature form of adrenomedullin in patients with
cardiac remodeling.
Heart
2002;
87
: 242–246.
17. Nishikimi T, Shibasaki I, Iıda H,
et al
. Molecular forms of adre-
nomedullin in pericardial fluid and plasma in patients with ischaemic
heart disease.
Clin Sci
2002;
102
: 669–677.
18. Anavekar NS, Solomon SD. Angiotensin II receptor blockade and
ventricular remodelling.
J Renin Angiotensin Aldosterone Syst
2005;
6
(1): 43–48.
19. Timmermans P, Benfield P, Chiu AT. Angiotensin II receptors and func-
tional correlates.
Am J Hypertens
1992;
5
: 221–235.
20. Schunkert H, Tang SS, Litwin SE,
et al
. Regulation of intrarenal and
circulating rennin-angiotensin systems in severe heart failure in the rat.
Cardiovasc Res
1993;
27
: 731–735.
21. Huang H, Arnal JF, Llorens-Cortes C,
et al
. Discrepancy between
plasma and lung angiotensin-converting enzyme activity in experimental
congestive heart failure. A novel aspect of endothelium dysfunction.
Circ Res
1994;
75
: 454–461.
22. Simon AD, Yazdani S, Wang W, Schwartz A, Rabbani LE. Circulating
levels of IL-1
β
, a prothrombotic cytokine, are elevated in unstable
angina versus stable angina.
J Thromb Thrombol
2000;
9
: 217–222.
23. Debrunner M, Schuiki E, Minder E,
et al
. Proinflammatory cytokines
in acute myocardial infraction with and without cardiogenic shock.
Clin
Res Cardiol
2008;
97
: 298–305.
24. Birner CM, Ulucan C, Fredersdorf S,
et al
. Head-to-head comparison
of BNP and IL-6 as markers of clinical and experimental heart failure:
superiority of BNP.
Cytokine
2007;
40
: 89–97.
25. Biasucci LM, Liuzzo G, Fantuzzi G,
et al
. Increasing levels of interleu-
kin (IL)-1Ra and IL-6 during the first 2 days of hospitalization in unsta-
ble angina are associated with increased risk of in-hospital coronary
events.
Circulation
1999;
99
: 2079–2084.
26. Warner SJ, Libby P. Human vascular smooth muscles: target for and
source of tumor necrosis factor.
J Immunol
1989;
142
: 100–109.
27. Tipping PG, Hancock WW. Production of tumor necrosis factor and
interleukin-1 by macrophages from human atheromatous plaques.
Am J
Pathol
1994;
142
: 1721–1782.
28. Torre-Amione G, Kapadia S, Lee J,
et al
. Tumor necrosis factor-
alpha and tumor necrosis factor receptors in the failing human heart.
Circulation
1996;
15
: 704–711.
29. Frenette PS. Locking a leukocyte integrin with statins.
N Eng J Med
2001;
345
: 1419–1421.
30. Brunetti ND, Munno I, Pellegrino PL, Ruggero V, Correale M, De
Gennaro L,
et al.
Inflammatory cytokines imbalance in the very early
phase of acute coronary syndrome: correlations with angiographic find-
ings and in-hospital events.
Inflammation
2011;
34
: 58–66.
31. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating
levels of tumor necrosis factor in severe chronic heart failure.
N Eng J
Med
1990;
323
: 236–241.
32. McMurray J, Abdullah I, Dargie H, Shapiro D. Increased concentra-
tions of tumor necrosis factor in ‘cachectic’ patients with severe heart
failure.
Br Heart J
1991;
66
: 356–358.
33. Torre-Amione G, Kapadia S, Lee J, Bies RD, Lebovitz R, Mann DL.
Expression and functional significance of tumor necrosis factor recep-
tors in human myocardium.
Circulation
1995;
92
: 1487–1493.
34. Dutka DP, Elborn, Delamere F, Shale DJ, Morris GK. Tumour necro-
sis factor
α
in severe congestive cardiac failure.
Br Heart J
1993;
70
:
141–143.
35. Tashiro H, Shimokawa H, Yamamoto K,
et al
. Monocyte-related
cytokines in acute myocardial infraction.
Am Heart J
1995;
130
:
446–452.
Events
CSI AFRICA 2016
CSI AFRICA 2016:
catheter interventions in congenital, structural and
valvar heart disease from 25–26 November 2016 in Kampala, Uganda.
Topics:
Paravalvar leak closure, left atrial appendage closure, pulmonary
valve replacement, echo evaluation of ASDs and VSDs, coarctation
stenting, ASD closure, VSD closure, trans-septal puncture, PDA
closure, pulmonary valvoplasty, mitral valvoplasty, how to develop
structural, congenital and valvar interventions in Africa, challenging
cases, problems and complications.
Who should attend:
Adult and paediatric interventional cardiologists,
cardiothoracic surgeons, anaesthesiologists, imaging specialists and
colleagues of other disciplines who wish to know more about the field.
All PASCAR members will receive a 20 % discount on registration fees.
Please register online:
www.csi-congress.org/africaSOSECAR – PAFCIC 2016 joint congress
4th congress of Senegalese Society of Cardiology (SOSECAR) and the
17th Pan-African (PASCAR) course on interventional cardiology, from
8-10 December 2016 at the Palais Des Congres of King Fahd Palace
Hotel, Dakar.
Main theme:
Interventional cardiology in Africa: challenges and
prospects
Sub-themes:
cardio-respiratory arrest: the heart and diabetes
Please submit abstract documents to:
sosecarpafcic2016@gmail.combefore the submission deadline: 25 October 2016.
23rd Annual Conference of The Egyptian Society
of Cardiothoracic Surgery
23rd annual conference of The Egyptian Society of Cardiothoracic
Surgery in collaboration with National Heart Institute of Egypt, from
4–7 April 2017 at Mena House Hotel, Cairo, Egypt.
Workshops:
RV-PA conduit implantation, electrophysiology anatomy for
ablation surgery, aortic repair, simulation for wire-based techniques, basic
anatomy of the heart for junior staff, TEE for surgeons and anaesthetics,
endoscopic vein harvesting, coronary anastomoses (hands on).
Main topics:
minimal invasive surgery, aortic root surgery, TEVAR,
surgery for heart failure, cardiovascular perfusion, RV-PA connections,
AV valve repair in infants, staging modalities in lung cancer, woman in
cardiac surgery, personal skill development for surgeons.
Kindly submit abstracts before the deadline 31 December 2016. Please
check the link for abstract form:
www.escts2017.com